ParkinsonCanadaV1, Ncbi, Merge, bibRecord, 001927

Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.

Identifieur interne : 001927 ( Ncbi/Merge ); précédent : 001926; suivant : 001928

Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.

Auteurs : I. Hsu [Canada] ; L G Parkinson [Canada] ; Y. Shen [Canada] ; A. Toro [Canada] ; T. Brown [Canada] ; H. Zhao [Canada] ; R C Bleackley [Canada] ; D J Granville [Canada]

Source :

Cell death & disease [ 2041-4889 ] ; 2014.

RBID : pubmed:25299783

English descriptors

KwdEn :
- Acute-Phase Proteins (genetics), Acute-Phase Proteins (metabolism), Animals, Cell Differentiation, Cell Proliferation, Collagen (metabolism), Diabetes Mellitus, Experimental (enzymology), Diabetes Mellitus, Experimental (genetics), Diabetes Mellitus, Experimental (metabolism), Diabetes Mellitus, Experimental (physiopathology), Disease Models, Animal, Extracellular Matrix (metabolism), Granzymes (metabolism), Humans, Male, Mice, Mice, Inbred C57BL, Serpins (genetics), Serpins (metabolism), Skin (blood supply), Skin (injuries), Skin (metabolism), Skin (physiopathology), Wound Healing.
MESH :
- chemical , genetics : Acute-Phase Proteins, Serpins.
- chemical , metabolism : Acute-Phase Proteins, Collagen, Granzymes, Serpins.
- blood supply : Skin.
- enzymology : Diabetes Mellitus, Experimental.
- genetics : Diabetes Mellitus, Experimental.
- injuries : Skin.
- metabolism : Diabetes Mellitus, Experimental, Extracellular Matrix, Skin.
- physiopathology : Diabetes Mellitus, Experimental, Skin.
- Animals, Cell Differentiation, Cell Proliferation, Disease Models, Animal, Humans, Male, Mice, Mice, Inbred C57BL, Wound Healing.

Abstract

Chronic, non-healing wounds are a major complication of diabetes and are characterized by chronic inflammation and excessive protease activity. Although once thought to function primarily as a pro-apoptotic serine protease, granzyme B (GzmB) can also accumulate in the extracellular matrix (ECM) during chronic inflammation and cleave ECM proteins that are essential for proper wound healing, including fibronectin. We hypothesized that GzmB contributes to the pathogenesis of impaired diabetic wound healing through excessive ECM degradation. In the present study, the murine serine protease inhibitor, serpina3n (SA3N), was administered to excisional wounds created on the dorsum of genetically induced type-II diabetic mice. Wound closure was monitored and skin wound samples were collected for analyses. Wound closure, including both re-epithelialization and contraction, were significantly increased in SA3N-treated wounds. Histological and immunohistochemical analyses of SA3N-treated wounds revealed a more mature, proliferative granulation tissue phenotype as indicated by increased cell proliferation, vascularization, fibroblast maturation and differentiation, and collagen deposition. Skin homogenates from SA3N-treated wounds also exhibited greater levels of full-length intact fibronectin compared with that of vehicle wounds. In addition, GzmB-induced detachment of mouse embryonic fibroblasts correlated with a rounded and clustered phenotype that was prevented by SA3N. In summary, topical administration of SA3N accelerated wound healing. Our findings suggest that GzmB contributes to the pathogenesis of diabetic wound healing through the proteolytic cleavage of fibronectin that is essential for normal wound closure, and that SA3N promotes granulation tissue maturation and collagen deposition.

DOI: 10.1038/cddis.2014.423
PubMed: 25299783

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000663
to stream PubMed, to step Curation: 000663
to stream PubMed, to step Checkpoint: 000663

Links to Exploration step

pubmed:25299783

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.</title>
<author><name sortKey="Hsu, I" sort="Hsu, I" uniqKey="Hsu I" first="I" last="Hsu">I. Hsu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Parkinson, L G" sort="Parkinson, L G" uniqKey="Parkinson L" first="L G" last="Parkinson">L G Parkinson</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shen, Y" sort="Shen, Y" uniqKey="Shen Y" first="Y" last="Shen">Y. Shen</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Toro, A" sort="Toro, A" uniqKey="Toro A" first="A" last="Toro">A. Toro</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brown, T" sort="Brown, T" uniqKey="Brown T" first="T" last="Brown">T. Brown</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zhao, H" sort="Zhao, H" uniqKey="Zhao H" first="H" last="Zhao">H. Zhao</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bleackley, R C" sort="Bleackley, R C" uniqKey="Bleackley R" first="R C" last="Bleackley">R C Bleackley</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Biochemistry, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Granville, D J" sort="Granville, D J" uniqKey="Granville D" first="D J" last="Granville">D J Granville</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25299783</idno>
<idno type="pmid">25299783</idno>
<idno type="doi">10.1038/cddis.2014.423</idno>
<idno type="wicri:Area/PubMed/Corpus">000663</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000663</idno>
<idno type="wicri:Area/PubMed/Curation">000663</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000663</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000663</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000663</idno>
<idno type="wicri:Area/Ncbi/Merge">001927</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.</title>
<author><name sortKey="Hsu, I" sort="Hsu, I" uniqKey="Hsu I" first="I" last="Hsu">I. Hsu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Parkinson, L G" sort="Parkinson, L G" uniqKey="Parkinson L" first="L G" last="Parkinson">L G Parkinson</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shen, Y" sort="Shen, Y" uniqKey="Shen Y" first="Y" last="Shen">Y. Shen</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Toro, A" sort="Toro, A" uniqKey="Toro A" first="A" last="Toro">A. Toro</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brown, T" sort="Brown, T" uniqKey="Brown T" first="T" last="Brown">T. Brown</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zhao, H" sort="Zhao, H" uniqKey="Zhao H" first="H" last="Zhao">H. Zhao</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bleackley, R C" sort="Bleackley, R C" uniqKey="Bleackley R" first="R C" last="Bleackley">R C Bleackley</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Biochemistry, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Granville, D J" sort="Granville, D J" uniqKey="Granville D" first="D J" last="Granville">D J Granville</name>
<affiliation wicri:level="1"><nlm:affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia</wicri:regionArea>
<wicri:noRegion>British Columbia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Cell death & disease</title>
<idno type="eISSN">2041-4889</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute-Phase Proteins (genetics)</term>
<term>Acute-Phase Proteins (metabolism)</term>
<term>Animals</term>
<term>Cell Differentiation</term>
<term>Cell Proliferation</term>
<term>Collagen (metabolism)</term>
<term>Diabetes Mellitus, Experimental (enzymology)</term>
<term>Diabetes Mellitus, Experimental (genetics)</term>
<term>Diabetes Mellitus, Experimental (metabolism)</term>
<term>Diabetes Mellitus, Experimental (physiopathology)</term>
<term>Disease Models, Animal</term>
<term>Extracellular Matrix (metabolism)</term>
<term>Granzymes (metabolism)</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Serpins (genetics)</term>
<term>Serpins (metabolism)</term>
<term>Skin (blood supply)</term>
<term>Skin (injuries)</term>
<term>Skin (metabolism)</term>
<term>Skin (physiopathology)</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Acute-Phase Proteins</term>
<term>Serpins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Acute-Phase Proteins</term>
<term>Collagen</term>
<term>Granzymes</term>
<term>Serpins</term>
</keywords>
<keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Diabetes Mellitus, Experimental</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Diabetes Mellitus, Experimental</term>
</keywords>
<keywords scheme="MESH" qualifier="injuries" xml:lang="en"><term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Diabetes Mellitus, Experimental</term>
<term>Extracellular Matrix</term>
<term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Diabetes Mellitus, Experimental</term>
<term>Skin</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Differentiation</term>
<term>Cell Proliferation</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Wound Healing</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chronic, non-healing wounds are a major complication of diabetes and are characterized by chronic inflammation and excessive protease activity. Although once thought to function primarily as a pro-apoptotic serine protease, granzyme B (GzmB) can also accumulate in the extracellular matrix (ECM) during chronic inflammation and cleave ECM proteins that are essential for proper wound healing, including fibronectin. We hypothesized that GzmB contributes to the pathogenesis of impaired diabetic wound healing through excessive ECM degradation. In the present study, the murine serine protease inhibitor, serpina3n (SA3N), was administered to excisional wounds created on the dorsum of genetically induced type-II diabetic mice. Wound closure was monitored and skin wound samples were collected for analyses. Wound closure, including both re-epithelialization and contraction, were significantly increased in SA3N-treated wounds. Histological and immunohistochemical analyses of SA3N-treated wounds revealed a more mature, proliferative granulation tissue phenotype as indicated by increased cell proliferation, vascularization, fibroblast maturation and differentiation, and collagen deposition. Skin homogenates from SA3N-treated wounds also exhibited greater levels of full-length intact fibronectin compared with that of vehicle wounds. In addition, GzmB-induced detachment of mouse embryonic fibroblasts correlated with a rounded and clustered phenotype that was prevented by SA3N. In summary, topical administration of SA3N accelerated wound healing. Our findings suggest that GzmB contributes to the pathogenesis of diabetic wound healing through the proteolytic cleavage of fibronectin that is essential for normal wound closure, and that SA3N promotes granulation tissue maturation and collagen deposition.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25299783</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>5</Volume>
<PubDate><Year>2014</Year>
<Month>Oct</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>Cell death & disease</Title>
<ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.</ArticleTitle>
<Pagination><MedlinePgn>e1458</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2014.423</ELocationID>
<Abstract><AbstractText>Chronic, non-healing wounds are a major complication of diabetes and are characterized by chronic inflammation and excessive protease activity. Although once thought to function primarily as a pro-apoptotic serine protease, granzyme B (GzmB) can also accumulate in the extracellular matrix (ECM) during chronic inflammation and cleave ECM proteins that are essential for proper wound healing, including fibronectin. We hypothesized that GzmB contributes to the pathogenesis of impaired diabetic wound healing through excessive ECM degradation. In the present study, the murine serine protease inhibitor, serpina3n (SA3N), was administered to excisional wounds created on the dorsum of genetically induced type-II diabetic mice. Wound closure was monitored and skin wound samples were collected for analyses. Wound closure, including both re-epithelialization and contraction, were significantly increased in SA3N-treated wounds. Histological and immunohistochemical analyses of SA3N-treated wounds revealed a more mature, proliferative granulation tissue phenotype as indicated by increased cell proliferation, vascularization, fibroblast maturation and differentiation, and collagen deposition. Skin homogenates from SA3N-treated wounds also exhibited greater levels of full-length intact fibronectin compared with that of vehicle wounds. In addition, GzmB-induced detachment of mouse embryonic fibroblasts correlated with a rounded and clustered phenotype that was prevented by SA3N. In summary, topical administration of SA3N accelerated wound healing. Our findings suggest that GzmB contributes to the pathogenesis of diabetic wound healing through the proteolytic cleavage of fibronectin that is essential for normal wound closure, and that SA3N promotes granulation tissue maturation and collagen deposition.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Parkinson</LastName>
<ForeName>L G</ForeName>
<Initials>LG</Initials>
<AffiliationInfo><Affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shen</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Toro</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Brown</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bleackley</LastName>
<ForeName>R C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo><Affiliation>Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Granville</LastName>
<ForeName>D J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo><Affiliation>1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>10</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Cell Death Dis</MedlineTA>
<NlmUniqueID>101524092</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516624">Serpina3n protein, mouse</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015843">Serpins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9007-34-5</RegistryNumber>
<NameOfSubstance UI="D003094">Collagen</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber>
<NameOfSubstance UI="D053804">Granzymes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1992 May;140(5):1261-8</RefSource>
<PMID Version="1">1580335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2009 Mar-Apr;17(2):153-62</RefSource>
<PMID Version="1">19320882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Oct 15;187(8):4119-28</RefSource>
<PMID Version="1">21911607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Jun 24;280(25):23549-58</RefSource>
<PMID Version="1">15843372</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Matrix Biol. 2013 Jan;32(1):14-22</RefSource>
<PMID Version="1">23228447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2008 Feb;15(2):251-62</RefSource>
<PMID Version="1">17975553</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunol Rev. 2010 May;235(1):105-16</RefSource>
<PMID Version="1">20536558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2001 Sep 7;276(36):33293-6</RefSource>
<PMID Version="1">11435447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2005 Dec 30;280(52):43168-78</RefSource>
<PMID Version="1">16141197</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2005 Jan-Feb;13(1):76-83</RefSource>
<PMID Version="1">15659039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Biochem. 1984;26(2):107-16</RefSource>
<PMID Version="1">6084665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 2009 Nov;89(11):1195-220</RefSource>
<PMID Version="1">19770840</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2011 Mar-Apr;19(2):134-48</RefSource>
<PMID Version="1">21362080</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2009 Nov-Dec;17(6):763-71</RefSource>
<PMID Version="1">19903300</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Tissue Antigens. 2012 Dec;80(6):477-87</RefSource>
<PMID Version="1">23137319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fibrogenesis Tissue Repair. 2011 Sep 16;4:21</RefSource>
<PMID Version="1">21923916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neuroimmunol. 2008 May 30;196(1-2):159-65</RefSource>
<PMID Version="1">18396337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2012 Jan;19(1):28-35</RefSource>
<PMID Version="1">22052191</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2013 Oct;20(10):1404-14</RefSource>
<PMID Version="1">23912712</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 1999 Mar;22(3):382-7</RefSource>
<PMID Version="1">10097914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 1987 Jun 5;49(5):679-85</RefSource>
<PMID Version="1">3555842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Dermatol. 1993 Feb;2(1):29-37</RefSource>
<PMID Version="1">8156167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 1999 Aug;178(2):107-12</RefSource>
<PMID Version="1">10487259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2005 Jan 12;293(2):217-28</RefSource>
<PMID Version="1">15644549</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exp Gerontol. 2011 Jun;46(6):489-99</RefSource>
<PMID Version="1">21316440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1996 Feb;106(2):335-41</RefSource>
<PMID Version="1">8601737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1996 Jan;106(1):102-8</RefSource>
<PMID Version="1">8592057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2000 Oct;23(10):1551-5</RefSource>
<PMID Version="1">11023151</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1992 Apr;98(4):410-6</RefSource>
<PMID Version="1">1372338</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2010 Feb;176(2):1038-49</RefSource>
<PMID Version="1">20035050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1995 Oct;105(4):572-8</RefSource>
<PMID Version="1">7561161</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 1990 Jul;63(1):21-9</RefSource>
<PMID Version="1">2197503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Mol Med. 2000 Oct;6(4):391-407</RefSource>
<PMID Version="1">10998429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2002 Jul;137(7):822-7</RefSource>
<PMID Version="1">12093340</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 Nov 12;366(9498):1736-43</RefSource>
<PMID Version="1">16291068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1993 Jul;122(1):103-11</RefSource>
<PMID Version="1">8314838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Diabetes Care. 2008 Apr;31(4):631-6</RefSource>
<PMID Version="1">18162494</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1993 Dec 15;151(12):7161-71</RefSource>
<PMID Version="1">8258716</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(10):e78939</RefSource>
<PMID Version="1">24205352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1993 Jul;101(1):64-8</RefSource>
<PMID Version="1">8392530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(3):e33163</RefSource>
<PMID Version="1">22479366</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cell Biol. 1998 Aug 10;142(3):873-81</RefSource>
<PMID Version="1">9700173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dermatol Sci. 2010 Aug;59(2):129-35</RefSource>
<PMID Version="1">20621450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 1999 Nov-Dec;7(6):442-52</RefSource>
<PMID Version="1">10633003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 2014 Jul;94(7):716-25</RefSource>
<PMID Version="1">24791744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Aspects Med. 2008 Oct;29(5):290-308</RefSource>
<PMID Version="1">18619669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2005 Jan-Feb;13(1):7-12</RefSource>
<PMID Version="1">15659031</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Derm Venereol. 2000 May;80(3):179-84</RefSource>
<PMID Version="1">10954207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 1990 Dec;63(6):825-31</RefSource>
<PMID Version="1">2255189</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2002 Jan-Feb;10(1):16-25</RefSource>
<PMID Version="1">11983003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Wound Repair Regen. 2009 Nov-Dec;17(6):832-9</RefSource>
<PMID Version="1">19903304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 1999 May;116(2):366-70</RefSource>
<PMID Version="1">10337032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Invest Dermatol. 1999 Apr;112(4):463-9</RefSource>
<PMID Version="1">10201530</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2004 Jun;136(3):542-8</RefSource>
<PMID Version="1">15147358</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Pharmacol Sci. 2013 Apr;34(4):233-42</RefSource>
<PMID Version="1">23541335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Epilepsia. 2009 Jun;50(6):1419-31</RefSource>
<PMID Version="1">19175398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Dis. 2011;2:e209</RefSource>
<PMID Version="1">21900960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO J. 1986 Dec 1;5(12):3267-74</RefSource>
<PMID Version="1">3545816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Vasc Surg. 1997 Dec;26(6):994-9; discussion 999-1001</RefSource>
<PMID Version="1">9423715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2006 Oct 15;177(8):5051-8</RefSource>
<PMID Version="1">17015688</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Periodontol. 2008 May;79(5):861-75</RefSource>
<PMID Version="1">18454665</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003094" MajorTopicYN="N">Collagen</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005109" MajorTopicYN="N">Extracellular Matrix</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053804" MajorTopicYN="N">Granzymes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015843" MajorTopicYN="N">Serpins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
<QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName>
<QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014945" MajorTopicYN="Y">Wound Healing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4237249</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>07</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>08</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>08</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25299783</ArticleId>
<ArticleId IdType="pii">cddis2014423</ArticleId>
<ArticleId IdType="doi">10.1038/cddis.2014.423</ArticleId>
<ArticleId IdType="pmc">PMC4237249</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Hsu, I" sort="Hsu, I" uniqKey="Hsu I" first="I" last="Hsu">I. Hsu</name>
</noRegion>
<name sortKey="Bleackley, R C" sort="Bleackley, R C" uniqKey="Bleackley R" first="R C" last="Bleackley">R C Bleackley</name>
<name sortKey="Brown, T" sort="Brown, T" uniqKey="Brown T" first="T" last="Brown">T. Brown</name>
<name sortKey="Granville, D J" sort="Granville, D J" uniqKey="Granville D" first="D J" last="Granville">D J Granville</name>
<name sortKey="Parkinson, L G" sort="Parkinson, L G" uniqKey="Parkinson L" first="L G" last="Parkinson">L G Parkinson</name>
<name sortKey="Shen, Y" sort="Shen, Y" uniqKey="Shen Y" first="Y" last="Shen">Y. Shen</name>
<name sortKey="Toro, A" sort="Toro, A" uniqKey="Toro A" first="A" last="Toro">A. Toro</name>
<name sortKey="Zhao, H" sort="Zhao, H" uniqKey="Zhao H" first="H" last="Zhao">H. Zhao</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001927 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001927 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:25299783
   |texte=   Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:25299783" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.

Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki